GSK Sues Moderna Over mRNA Patent Infringement
GlaxoSmithKline (NYSE: GSK), the British drugmaker, sued Moderna (NASDAQ: MRNA) in U.S. federal court in Delaware on Tuesday, accusing it […]
GSK Sues Moderna Over mRNA Patent Infringement Read More »
NASDAQ: MRNA
Pfizer vs. Moderna: COVID Vaccine Patents Battle to Go to Appeal in UK
LONDON – Pfizer (NYSE: PFE) and Moderna’s (NASDAQ: MRNA) legal battle over their rival COVID-19 vaccines will continue after London’s
Pfizer vs. Moderna: COVID Vaccine Patents Battle to Go to Appeal in UK Read More »
FDA Greenlights Updated COVID Vaccines to Combat New Variants Ahead of Fall Campaign
On Thursday, the U.S. Food and Drug Administration approved updated COVID-19 vaccines made by Pfizer (NYSE: PFE) and Moderna (NASDAQ:
FDA Greenlights Updated COVID Vaccines to Combat New Variants Ahead of Fall Campaign Read More »
